Northern Trust Corp Moderna, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 2,604,183 shares of MRNA stock, worth $96 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,604,183

Previous 2,839,267 8.28%

Holding current value

$96 Million

Previous $337 Million 48.38%

% of portfolio

0.03%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$63.64 - $125.14 $15 Million - $29.4 Million	-235,084 Reduced 8.28%	2,604,183 $174 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $3 Million - $4.95 Million	-29,687 Reduced 1.03%	2,839,267 $337 Million
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $8.8 Million - $11.9 Million	-103,042 Reduced 3.47%	2,868,954 $306 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $65,339 - $98,164	940 Added 0.03%	2,971,996 $296 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $5.32 Million - $6.99 Million	55,177 Added 1.89%	2,971,056 $307 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $34.1 Million - $46.2 Million	-287,565 Reduced 8.98%	2,915,879 $354 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $9.1 Million - $13.2 Million	-67,114 Reduced 2.05%	3,203,444 $492 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $5.3 Million - $9.4 Million	44,752 Added 1.39%	3,270,558 $587 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $14.4 Million - $23.6 Million	-121,782 Reduced 3.64%	3,225,806 $381 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $18.2 Million - $27.5 Million	-155,737 Reduced 4.45%	3,347,588 $478 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $2.58 Million - $4.8 Million	20,416 Added 0.59%	3,503,325 $603 Million
Q4 2021 Feb 08, 2022	BUY	$225.82 - $368.51 $5.32 Million - $8.68 Million	23,555 Added 0.68%	3,482,909 $885 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $335 Million - $732 Million	1,510,266 Added 77.49%	3,459,354 $1.33 Billion
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $14.6 Million - $26.4 Million	112,251 Added 6.11%	1,949,088 $458 Million
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $1.25 Million - $2.13 Million	11,466 Added 0.63%	1,836,837 $241 Million
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $105,183 - $271,776	1,600 Added 0.09%	1,825,371 $191 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $303,760 - $530,211	-5,590 Reduced 0.31%	1,823,771 $129 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $21.6 Million - $58.3 Million	729,335 Added 66.3%	1,829,361 $117 Million
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $2.3 Million - $4.09 Million	129,361 Added 13.33%	1,100,026 $32.9 Million
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $546,641 - $835,069	39,242 Added 4.21%	970,665 $19 Million
Q3 2019 Nov 13, 2019	BUY	$12.26 - $18.07 $9.12 Million - $13.4 Million	743,929 Added 396.77%	931,423 $14.8 Million
Q2 2019 Aug 13, 2019	BUY	$13.7 - $28.34 $1.89 Million - $3.91 Million	138,031 Added 279.06%	187,494 $2.74 Million
Q1 2019 May 13, 2019	BUY	$14.45 - $23.7 $714,740 - $1.17 Million	49,463 New	49,463 $1.01 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Moderna, Inc. Transaction History